Latest On BELLUS Health Inc (BLU):
About BELLUS Health Inc (BLU):
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.
General
- Name BELLUS Health Inc
- Symbol BLU
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 32
- Last Split Factor277:1000
- Last Split Date2019-08-19
- Fiscal Year EndDecember
- IPO Date2008-12-29
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.bellushealth.com
Valuation
- Price/Sales (Trailing 12 Mt.) 16801.99
- Price/Book (Most Recent Quarter) 2.27
- Enterprise Value Revenue 15599.14
Financials
- Most Recent Quarter 2020-12-31
- Operating Margin -219613%
- Return on Assets -17%
- Return on Equity -27%
- Revenue 15000
- Earnings Per Share -$0.51
- Revenue Per Share $0
- Gross Profit 15000
- Quarterly Earnings Growth -42.9%
Highlights
- Market Capitalization 315.43 million
Share Statistics
- Shares Outstanding 78.34 million
- Shares Float 41.88 million
- % Held by Insiders 2195%
- % Held by Institutions 47.48%
- Shares Short 2.15 million
- Shares Short Prior Month 1.14 million
- Short Ratio 1.04
- Short % of Shares Outstanding 3%
Technicals
- Beta -0.33
- 52 Week High $12.03
- 52 Week Low $2.12
- 50 Day Moving Average 3.91
- 200 Day Moving Average 3.05
Dividends
- Dividend Date 2019-08-19
- ExDividend Date N/A
- Dividend Yield 0%
BELLUS Health Inc (BLU) Dividend Calendar:
BLU's last dividend payment was made to shareholders on August 19, 2019.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
BELLUS Health Inc (BLU) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | -$0.11 | -$0.13 | 16.77% |
2020-09-30 | 2020-11-12 | $3000 | -$0.09 | -$0.14 | 34.26% |
2020-06-30 | 2020-08-13 | $N/A | -$0.14 | -$0.18 | 21.32% |
2020-03-31 | 2020-05-14 | $4000 | -$0.18 | -$0.16 | -11.55% |
2019-12-31 | 2020-02-27 | $9000 | -$0.19 | -$0.11 | -71.78% |
2019-09-30 | 2019-11-14 | $9000 | -$0.14 | -$0.17 | 17.93% |
2019-06-30 | 2019-08-08 | $8000 | -$0.14 | -$0.07 | -98.98% |
2019-03-31 | 2019-05-08 | $9000 | -$0.08 | -$0.03 | -192.34% |
2018-12-31 | 2019-02-21 | $9000 | -$0.07 | -$0.05 | -32.77% |
2018-09-30 | 2018-11-14 | $9000 | -$0.07 | -$0.06 | -21.52% |
2018-06-30 | 2018-08-08 | -$0.04 | -$0.05 | 26.96% | |
2018-03-31 | 2018-05-15 | -$0.06 | -$0.03 | -97.88% | |
2017-12-31 | 2018-02-21 | -$0.06 | -$0.06 | -0.69% | |
2017-09-30 | 2017-11-08 | -$0.08 | |||
2017-06-30 | 2017-08-09 | $0.01 | |||
2017-03-31 | 2017-05-11 | $0.05 | |||
2016-12-31 | 2017-02-28 | -$0.02 | |||
2016-09-30 | 2016-11-10 | -$0.03 | |||
2016-06-30 | 2016-08-09 | -$0.03 | -$0.06 | 51.25% | |
2016-03-31 | 2016-05-12 | -$0.03 | -$0.03 | -1.08% | |
2015-12-31 | 2016-02-24 | $0.05 | -$0.01 | 504.58% | |
2015-09-30 | 2015-11-12 | -$0.01 | |||
2015-06-30 | 2015-08-12 | -$0.03 | |||
2015-03-31 | 2015-05-12 | $-0.00 | |||
2014-12-31 | 2015-02-25 | $0.01 | |||
2014-09-30 | 2014-11-05 | -$0.05 | |||
2014-06-30 | 2014-08-13 | -$0.05 | |||
2014-03-31 | 2014-05-08 | -$0.05 | |||
2013-12-31 | 2014-02-26 | -$0.04 | |||
2013-09-30 | 2013-11-06 | $0.07 | |||
2013-06-30 | 2013-08-07 | -$0.06 | |||
2013-03-31 | 2013-05-16 | -$0.04 | |||
2012-12-31 | 2013-02-27 | -$0.04 | |||
2012-09-30 | 2012-11-08 | -$0.02 | |||
2012-06-30 | 2012-08-08 | -$1.37 | |||
2012-03-31 | 2012-05-15 | -$1.20 | |||
2011-12-31 | 2012-02-23 | -$0.08 | |||
2011-09-30 | 2011-11-09 | -$0.22 | |||
2011-06-30 | 2011-08-08 | -$0.14 | |||
2011-03-31 | 2011-05-11 | -$0.27 | |||
2010-12-31 | 2011-02-23 | -$1.93 | |||
2010-09-30 | 2010-11-10 | -$3.09 | |||
2010-06-30 | 2010-08-09 | -$2.91 | |||
2010-03-31 | 2010-05-12 | -$2.09 | |||
2009-12-31 | 2010-02-25 | -$3.24 | |||
2009-09-30 | 2009-11-11 | -$3.81 | |||
2009-06-30 | 2009-08-12 | -$3.12 | |||
2009-03-31 | 2009-05-06 | -$21.32 | |||
2008-12-31 | 2009-02-26 | -$24.84 | -$22.68 | -9.52% | |
2008-09-30 | 2008-11-10 | -$23.76 | -$19.44 | -22.22% | |
2008-06-30 | 2008-08-05 | -$28.08 | -$20.52 | -36.84% | |
2008-03-31 | 2008-05-05 | -$28.08 | -$25.92 | -8.33% | |
2007-12-31 | 2008-02-20 | -$35.64 | -$22.68 | -57.14% | |
2007-09-30 | 2007-11-07 | -$31.32 | -$43.03 | 27.21% | |
2007-06-30 | 2007-08-09 | -$81.00 | -$53.01 | -52.8% | |
2007-03-31 | 2007-05-08 | -$58.32 | -$47.73 | -22.19% | |
2006-12-31 | 2007-02-21 | -$47.52 | -$44.67 | -6.38% | |
2006-09-30 | 2006-11-08 | -$46.44 | -$43.13 | -7.67% | |
2006-06-30 | 2006-08-09 | -$50.76 | -$45.35 | -11.93% | |
2006-03-31 | 2006-05-09 | -$42.12 | -$44.04 | 4.36% | |
2005-12-31 | 2006-02-23 | -$38.88 | -$49.68 | 21.74% | |
2005-09-30 | 2005-11-08 | -$51.84 | -$42.84 | -21.01% | |
2005-06-30 | 2005-08-10 | -$46.44 | -$44.40 | -4.59% | |
2005-03-31 | 2005-05-12 | -$46.44 | -$44.02 | -5.5% | |
2004-12-31 | 2005-02-22 | -$45.36 | -$37.08 | -22.33% | |
2004-09-30 | 2004-11-04 | -$37.80 | -$52.92 | 28.57% | |
2004-06-30 | 2004-08-17 | -$38.83 | -$34.99 | -10.97% | |
2004-03-31 | 2004-05-11 | -$24.20 | -$23.28 | -3.95% | |
2003-12-31 | 2004-02-23 | -$11.28 | -$17.66 | 36.13% | |
2003-09-30 | 2003-11-12 | -$20.57 | -$17.28 | -19.04% | |
2003-06-30 | 2003-08-18 | -$23.88 | -$21.02 | -13.61% | |
2003-03-31 | 2003-05-14 | -$15.52 | -$20.18 | 23.09% |
BELLUS Health Inc (BLU) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
BELLUS Health Inc (BLU) Chart:
BELLUS Health Inc (BLU) News:
Below you will find a list of latest news for BELLUS Health Inc (BLU) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
BELLUS Health Inc (BLU) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest BLU Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 100 | $7.76 |
Jun 13, 2022 7:59 PM EST | 800 | $7.76 |
Jun 13, 2022 7:59 PM EST | 100 | $7.76 |
Jun 13, 2022 7:59 PM EST | 2 | $7.76 |
Jun 13, 2022 7:59 PM EST | 22 | $7.76 |
BELLUS Health Inc (BLU) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000094787120000554/0000947871-20-000554-index.htm |
2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000031506620000855/0000315066-20-000855-index.htm |
2020-01-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000089534520000035/0000895345-20-000035-index.htm |
2020-10-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000089914020000487/0000899140-20-000487-index.htm |
2019-09-18 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000094787119000690/0000947871-19-000690-index.htm |
2020-06-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000094787120000554/0000947871-20-000554-index.htm |
2020-10-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000094787120000805/0000947871-20-000805-index.htm |
2009-06-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000095012309011669/0000950123-09-011669-index.htm |
2009-06-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000095012309018643/0000950123-09-018643-index.htm |
2009-07-09 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000095012309021181/0000950123-09-021181-index.htm |
2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000095014220000387/0000950142-20-000387-index.htm |
2019-11-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000110465919064113/0001104659-19-064113-index.htm |
2019-12-20 | F-10 | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1259942/000110465919074962/0001104659-19-074962-index.htm |
2019-12-20 | F-X | Appointment of Agent for Service of Process and Undertaking | https://www.sec.gov/Archives/edgar/data/1259942/000110465919075023/0001104659-19-075023-index.htm |
2020-01-17 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1259942/000110465920005127/0001104659-20-005127-index.htm |
2020-02-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000110465920011938/0001104659-20-011938-index.htm |
2020-02-27 | 40-F | Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920026291/0001104659-20-026291-index.htm |
2020-03-23 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920037064/0001104659-20-037064-index.htm |
2020-03-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920037088/0001104659-20-037088-index.htm |
2020-04-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920044004/0001104659-20-044004-index.htm |
2020-04-21 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1259942/000110465920049294/0001104659-20-049294-index.htm |
2020-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920061708/0001104659-20-061708-index.htm |
2020-05-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1259942/000110465920061727/0001104659-20-061727-index.htm |
2020-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920094650/0001104659-20-094650-index.htm |
2020-10-19 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920116130/0001104659-20-116130-index.htm |
2020-10-20 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920116449/0001104659-20-116449-index.htm |
2020-10-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000110465920116459/0001104659-20-116459-index.htm |
2019-09-03 | F-10 | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043097/0001144204-19-043097-index.htm |
2019-09-03 | F-X | Appointment of Agent for Service of Process and Undertaking | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043103/0001144204-19-043103-index.htm |
2019-09-03 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043106/0001144204-19-043106-index.htm |
2019-09-04 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043428/0001144204-19-043428-index.htm |
2019-09-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043506/0001144204-19-043506-index.htm |
2019-09-05 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043567/0001144204-19-043567-index.htm |
2019-09-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000114420419043877/0001144204-19-043877-index.htm |
2019-09-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000114420419044841/0001144204-19-044841-index.htm |
2019-09-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000114420419044904/0001144204-19-044904-index.htm |
2019-09-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1259942/000114420419045836/0001144204-19-045836-index.htm |
2019-11-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752319002257/0001157523-19-002257-index.htm |
2019-11-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752319002266/0001157523-19-002266-index.htm |
2020-02-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000235/0001157523-20-000235-index.htm |
2020-02-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000283/0001157523-20-000283-index.htm |
2020-03-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000378/0001157523-20-000378-index.htm |
2020-03-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000417/0001157523-20-000417-index.htm |
2020-04-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000473/0001157523-20-000473-index.htm |
2020-05-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000667/0001157523-20-000667-index.htm |
2020-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000670/0001157523-20-000670-index.htm |
2020-05-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000737/0001157523-20-000737-index.htm |
2020-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000747/0001157523-20-000747-index.htm |
2020-05-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000818/0001157523-20-000818-index.htm |
2020-07-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320000956/0001157523-20-000956-index.htm |
2020-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320001179/0001157523-20-001179-index.htm |
2020-09-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320001228/0001157523-20-001228-index.htm |
2020-09-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320001234/0001157523-20-001234-index.htm |
2020-10-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000115752320001322/0001157523-20-001322-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000117266120000499/0001172661-20-000499-index.htm |
2020-03-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000117625620000063/0001176256-20-000063-index.htm |
2020-04-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000117625620000126/0001176256-20-000126-index.htm |
2009-03-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000064/0001206212-09-000064-index.htm |
2009-04-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000068/0001206212-09-000068-index.htm |
2009-04-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000070/0001206212-09-000070-index.htm |
2009-04-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000072/0001206212-09-000072-index.htm |
2009-04-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000075/0001206212-09-000075-index.htm |
2009-04-21 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000082/0001206212-09-000082-index.htm |
2009-04-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000088/0001206212-09-000088-index.htm |
2009-04-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000092/0001206212-09-000092-index.htm |
2009-05-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000103/0001206212-09-000103-index.htm |
2009-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000108/0001206212-09-000108-index.htm |
2009-05-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000110/0001206212-09-000110-index.htm |
2009-05-11 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000113/0001206212-09-000113-index.htm |
2009-05-11 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000114/0001206212-09-000114-index.htm |
2009-05-12 | 15-12G | Securities registration termination [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1259942/000120621209000118/0001206212-09-000118-index.htm |
2017-12-21 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1259942/000125994217000004/0001259942-17-000004-index.htm |
2019-01-11 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1259942/000125994219000001/0001259942-19-000001-index.htm |
2019-01-29 | D/A | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1259942/000125994219000002/0001259942-19-000002-index.htm |
2019-09-04 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1259942/000135445719000433/0001354457-19-000433-index.htm |
2019-09-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000149315219014146/0001493152-19-014146-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1259942/000149315220002417/0001493152-20-002417-index.htm |
2020-01-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1259942/999999999520000127/9999999995-20-000127-index.htm |